Proposed Substances To Be Evaluated for Toxicological Profile Development, 17177-17178 [2018-08090]
Download as PDF
<![CDATA[
Federal Register / Vol. 83, No. 75 / Wednesday, April 18, 2018 / Notices
provide comment should contact the
DFO directly.
Oral Statements: In general,
individuals or groups requesting an oral
presentation at a public meeting will be
limited to five minutes. Persons
interested in providing oral statements
at the May 31–June 1, 2018, meeting
should contact Mr. Thomas Carpenter,
DFO, in writing (preferably via email) at
the contact information noted above by
May 22, 2018 to be placed on the list of
registered speakers.
Written Statements: Written
statements for the May 31–June 1, 2018,
meeting should be received in the SAB
Staff Office by March 22, 2018, so that
the information can be made available
to the SAB for its consideration prior to
the meeting. Written statements should
be supplied to the DFO at the contact
information above via email (preferred)
or in hard copy with original signature.
Submitters are requested to provide a
signed and unsigned version of each
document because the SAB Staff Office
does not publish documents with
signatures on its websites. Members of
the public should be aware that their
personal contact information, if
included in any written comments, may
be posted to the SAB website.
Copyrighted material will not be posted
without explicit permission of the
copyright holder.
Accessibility: For information on
access or services for individuals with
disabilities, please contact Mr.
Carpenter at the phone number or email
address noted above, preferably at least
ten days prior to the meeting, to give the
EPA as much time as possible to process
your request.
17177
Dated: April 12, 2018.
Khanna Johnston,
Deputy Director, EPA Science Advisory Board
Staff Office.
[FR Doc. 2018–08135 Filed 4–17–18; 8:45 am]
BILLING CODE 6560–50–P
FEDERAL COMMUNICATIONS
COMMISSION
Deletion of Item From Sunshine Act
Meeting
April 13, 2016.
The following item has been deleted
from the list of items scheduled for
consideration at the Tuesday, April 17,
2018, Open Meeting and previously
listed in the Commission’s Notice of
April 10, 2018.
Item No.
Bureau
Subject
7 ...................
MEDIA .......................................................
TITLE: Amendment of Section 73.624(g) of the Commission’s Rules Regarding
Submission of FCC Form 2100, Schedule G, Used to Report TV Stations’ Ancillary or Supplementary Services (MB Docket No. 17–264); Modernization of Media
Regulation Initiative (MB Docket No. 17–105). SUMMARY: The Commission will
consider a Report and Order that would revise Section 73.624(g) of its rules to
reduce broadcaster reporting obligations relating to the provision of ancillary or
supplementary services.
Federal Communications Commission.
Katura Jackson,
Federal Register Liaison Officer, Office of the
Secretary.
[FR Doc. 2018–08207 Filed 4–16–18; 11:15 am]
BILLING CODE 6712–01–P
Contact Person for More Information:
Kimberly Weaver, Director, Office of
External Affairs, (202) 942–1640.
Dated: April 12, 2018.
Dharmesh Vashee,
Deputy General Counsel, Federal Retirement
Thrift Investment Board.
[FR Doc. 2018–08089 Filed 4–17–18; 8:45 am]
BILLING CODE P
Meeting Agenda; April 23, 2018, In
Person, 8:30 a.m.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Open Session
amozie on DSK30RV082PROD with NOTICES
FEDERAL RETIREMENT THRIFT
INVESTMENT BOARD
Agency for Toxic Substances and
Disease Registry
1. Approval of the Meeting Minutes for
the March 26, 2018 Board Member
Meeting
2. Monthly Reports
(a) Participant Activity Report
(b) Legislative Report
3. Quarterly Reports
(c) Investment Performance
(d) Budget Review
(e) Audit Status
4. OCFO Annual Report
5. Internal Audit
6. Annual Financial Audit—CLA
7. DOL Presentation
8. IT Update
Closed Session
Information covered under 5 U.S.C.
552b (c)(9)(B).
VerDate Sep<11>2014
17:31 Apr 17, 2018
Jkt 244001
[Docket No. ATSDR–2018–0003]
Proposed Substances To Be Evaluated
for Toxicological Profile Development
Agency for Toxic Substances
and Disease Registry (ATSDR),
Department of Health and Human
Services (HHS).
ACTION: Request for comments on
proposed substances to be evaluated for
Toxicological Profile development.
AGENCY:
The Agency for Toxic
Substances and Disease Registry
(ATSDR) within the Department of
Health and Human Services is initiating
the development of another set of
Toxicological Profiles. This notice
SUMMARY:
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
solicits public nominations of
substances for ATSDR to evaluate for
Toxicological Profile development.
ATSDR will consider nominations from
the Substance Priority List, as well as
any non-Comprehensive Environmental
Response, Compensation, and Liability
Act of 1980 (CERLA) substances that
may have public health implications, on
the basis of ATSDR’s authority to
prepare Toxicological Profiles for
substances not found at sites on the
National Priorities List. The agency will
do so in order to ‘‘. . . establish and
maintain inventory of literature,
research, and studies on the health
effects of toxic substances’’, to respond
to requests for consultation, and to
support the site-specific response
actions conducted by ATSDR, as
otherwise necessary.
DATES: Nominations from the Substance
Priority List and/or additional
substances must be submitted by May
18, 2018.
ADDRESSES: You may submit
nominations, identified by Docket No.
ATSDR–2018–0003 by any of the
following methods:
• Internet: Access the Federal
eRulemaking portal at
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Division of Toxicology and
Human Health Sciences, Agency for
E:\FR\FM\18APN1.SGM
18APN1
17178
Federal Register / Vol. 83, No. 75 / Wednesday, April 18, 2018 / Notices
Toxic Substances and Disease Registry,
1600 Clifton Rd. NE, MS F–57, Atlanta,
GA 30329. Attn: Docket No. ATSDR–
2018–0003.
Instructions: All submissions must
include the agency name and docket
number for this notice. All relevant
comments will be posted without
change. This means that no confidential
business information or other
confidential information should be
submitted in response to this notice.
Refer to the section Submission of
Nominations (below) for the specific
information required.
FOR FURTHER INFORMATION CONTACT: For
further information, please contact
Susan Z. Ingber, Division of Toxicology
and Human Health Sciences, Agency for
Toxic Substances and Disease Registry,
1600 Clifton Rd. NE, MS F–57, Atlanta,
GA 30329, Email: wng7@cdc.gov;
phone: 770.488.0605.
SUPPLEMENTARY INFORMATION: The
Superfund Amendments and
Reauthorization Act of 1986 (SARA) [42
U.S.C. 9601 et seq.] amended the
Comprehensive Environmental
Response, Compensation, and Liability
Act of 1980 (CERCLA or Superfund) [42
U.S.C. 9601 et seq.] by establishing
certain requirements for ATSDR and the
U.S. Environmental Protection Agency
(EPA) with regard to hazardous
substances most commonly found at
facilities on the CERCLA National
Priorities List (NPL). Among these
statutory requirements is a mandate for
the Administrator of ATSDR to prepare
Toxicological Profiles for each
substance included on the Priority List
of Hazardous Substances. This list
identifies 275 hazardous substances that
ATSDR and EPA have determined pose
the most significant current potential
threat to human health.
Substances To Be Evaluated for
Toxicological Profile Development
amozie on DSK30RV082PROD with NOTICES
Each year, ATSDR develops a list of
substances to be considered for
Toxicological Profile development. The
nomination process includes
consideration of all substances on
ATSDR’s Substance Priority List (SPL),
as well as other substances nominated
by the public. The SPL may be found at
the following website:
www.atsdr.cdc.gov/SPL.
Submission of Nominations for
Toxicological Profile Development
Today’s notice invites voluntary
public nominations for substances
included on the SPL and for substances
not listed on the SPL. All nominations
should include the full name of the
nominator, affiliation, and email
VerDate Sep<11>2014
17:31 Apr 17, 2018
Jkt 244001
address. When nominating a non-SPL
substance, please include the rationale
for the nomination. Please note that
email addresses will not be posted on
regulations.gov.
ATSDR will evaluate data and
information associated with nominated
substances and will determine the final
list of substances to be chosen for
Toxicological Profile development.
Substances will be chosen according to
ATSDR’s specific guidelines for
selection. These guidelines can be found
in the Selection Criteria, which may be
accessed at www.atsdr.cdc.gov/
toxprofiles/guidance/ATSDR_TP_
Selection%20Criteria.pdf.
Please ensure that your comments are
submitted within the specified
nomination period. Nominations
received after the closing date will be
marked as late and may be considered
only if time and resources permit.
Pamela Protzel Berman,
Director, Office of Policy, Planning and
Partnerships, Agency for Toxic Substances
and Disease Registry.
[FR Doc. 2018–08090 Filed 4–17–18; 8:45 am]
BILLING CODE 4163–70–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Announcement of Meeting of the
Secretary’s Advisory Committee on
National Health Promotion and Disease
Prevention Objectives for 2030
Office of Disease Prevention
and Health Promotion, Office of the
Assistant Secretary for Health, Office of
the Secretary, Department of Health and
Human Services.
ACTION: Notice.
AGENCY:
The U.S. Department of
Health and Human Services (HHS)
announces the next meeting of the
Secretary’s Advisory Committee on
National Health Promotion and Disease
Prevention Objectives for 2030
(Committee) regarding the development
of national health promotion and
disease prevention objectives for 2030.
This meeting will be held online via
webinar and is open to the public. The
Committee will discuss the nation’s
health promotion and disease
prevention objectives and will provide
recommendations to improve health
status and reduce health risks for the
nation by the year 2030. The Committee
will further develop recommendations
regarding Leading Health Indicators and
recommendations for setting targets for
the Healthy People 2030 objectives.
Pursuant to the Committee’s charter, the
Committee’s advice must assist the
SUMMARY:
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
Secretary in reducing the number of
objectives while ensuring that the
selection criteria identifies the most
critical public health issues that are
high-impact priorities supported by
current national data.
DATES: The Committee will meet on
May 14, 2018, from 1:00 p.m. to 4:00
p.m. Eastern Time (ET).
ADDRESSES: The meeting will be held
online via webinar. To register to attend
the meeting, please visit the Healthy
People website at https://
www.healthypeople.gov.
FOR FURTHER INFORMATION CONTACT:
Emmeline Ochiai, Designated Federal
Official, Secretary’s Advisory
Committee on National Health
Promotion and Disease Prevention
Objectives for 2030, U.S. Department of
Health and Human Services, Office of
the Assistant Secretary for Health,
Office of Disease Prevention and Health
Promotion, 1101 Wootton Parkway,
Room LL–100, Rockville, MD 20852,
(240) 453–8280 (telephone), (240) 453–
8281 (fax). Additional information is
available on the Healthy People website
at https://www.healthypeople.gov.
SUPPLEMENTARY INFORMATION: The
names and biographies of the
Committee members are available at
https://www.healthypeople.gov/2020/
about/history-development/healthypeople-2030-advisory-committee.
Purpose of Meeting: Through the
Healthy People initiative, HHS leverages
scientific insights and lessons from the
past decade, along with new knowledge
of current data, trends, and innovations,
to develop the next iteration of national
health promotion and disease
prevention objectives. Healthy People
provides science-based, 10-year national
objectives for promoting health and
preventing disease. Since 1979, Healthy
People has set and monitored national
health objectives that meet a broad
range of health needs, encourage
collaboration across sectors, guide
individuals toward making informed
health decisions, and measure the
impact of our prevention and health
promotion activities. Healthy People
2030 health objectives will reflect
assessments of major risks to health and
wellness, changing public health
priorities, and emerging technologies
related to our nation’s health
preparedness and prevention.
Public Participation at Meeting:
Members of the public are invited to
join the online Committee meeting.
There will be no opportunity for oral
public comments during this online
Committee meeting. However, written
comments are welcome throughout the
entire development process of the
E:\FR\FM\18APN1.SGM
18APN1
]]>Agencies
[Federal Register Volume 83, Number 75 (Wednesday, April 18, 2018)]
[Notices]
[Pages 17177-17178]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-08090]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Toxic Substances and Disease Registry
[Docket No. ATSDR-2018-0003]
Proposed Substances To Be Evaluated for Toxicological Profile
Development
AGENCY: Agency for Toxic Substances and Disease Registry (ATSDR),
Department of Health and Human Services (HHS).
ACTION: Request for comments on proposed substances to be evaluated for
Toxicological Profile development.
-----------------------------------------------------------------------
SUMMARY: The Agency for Toxic Substances and Disease Registry (ATSDR)
within the Department of Health and Human Services is initiating the
development of another set of Toxicological Profiles. This notice
solicits public nominations of substances for ATSDR to evaluate for
Toxicological Profile development. ATSDR will consider nominations from
the Substance Priority List, as well as any non-Comprehensive
Environmental Response, Compensation, and Liability Act of 1980 (CERLA)
substances that may have public health implications, on the basis of
ATSDR's authority to prepare Toxicological Profiles for substances not
found at sites on the National Priorities List. The agency will do so
in order to ``. . . establish and maintain inventory of literature,
research, and studies on the health effects of toxic substances'', to
respond to requests for consultation, and to support the site-specific
response actions conducted by ATSDR, as otherwise necessary.
DATES: Nominations from the Substance Priority List and/or additional
substances must be submitted by May 18, 2018.
ADDRESSES: You may submit nominations, identified by Docket No. ATSDR-
2018-0003 by any of the following methods:
Internet: Access the Federal eRulemaking portal at
www.regulations.gov. Follow the instructions for submitting comments.
Mail: Division of Toxicology and Human Health Sciences,
Agency for
[[Page 17178]]
Toxic Substances and Disease Registry, 1600 Clifton Rd. NE, MS F-57,
Atlanta, GA 30329. Attn: Docket No. ATSDR-2018-0003.
Instructions: All submissions must include the agency name and
docket number for this notice. All relevant comments will be posted
without change. This means that no confidential business information or
other confidential information should be submitted in response to this
notice. Refer to the section Submission of Nominations (below) for the
specific information required.
FOR FURTHER INFORMATION CONTACT: For further information, please
contact Susan Z. Ingber, Division of Toxicology and Human Health
Sciences, Agency for Toxic Substances and Disease Registry, 1600
Clifton Rd. NE, MS F-57, Atlanta, GA 30329, Email: [email protected]; phone:
770.488.0605.
SUPPLEMENTARY INFORMATION: The Superfund Amendments and Reauthorization
Act of 1986 (SARA) [42 U.S.C. 9601 et seq.] amended the Comprehensive
Environmental Response, Compensation, and Liability Act of 1980 (CERCLA
or Superfund) [42 U.S.C. 9601 et seq.] by establishing certain
requirements for ATSDR and the U.S. Environmental Protection Agency
(EPA) with regard to hazardous substances most commonly found at
facilities on the CERCLA National Priorities List (NPL). Among these
statutory requirements is a mandate for the Administrator of ATSDR to
prepare Toxicological Profiles for each substance included on the
Priority List of Hazardous Substances. This list identifies 275
hazardous substances that ATSDR and EPA have determined pose the most
significant current potential threat to human health.
Substances To Be Evaluated for Toxicological Profile Development
Each year, ATSDR develops a list of substances to be considered for
Toxicological Profile development. The nomination process includes
consideration of all substances on ATSDR's Substance Priority List
(SPL), as well as other substances nominated by the public. The SPL may
be found at the following website: www.atsdr.cdc.gov/SPL.
Submission of Nominations for Toxicological Profile Development
Today's notice invites voluntary public nominations for substances
included on the SPL and for substances not listed on the SPL. All
nominations should include the full name of the nominator, affiliation,
and email address. When nominating a non-SPL substance, please include
the rationale for the nomination. Please note that email addresses will
not be posted on regulations.gov.
ATSDR will evaluate data and information associated with nominated
substances and will determine the final list of substances to be chosen
for Toxicological Profile development. Substances will be chosen
according to ATSDR's specific guidelines for selection. These
guidelines can be found in the Selection Criteria, which may be
accessed at www.atsdr.cdc.gov/toxprofiles/guidance/ATSDR_TP_Selection%20Criteria.pdf.
Please ensure that your comments are submitted within the specified
nomination period. Nominations received after the closing date will be
marked as late and may be considered only if time and resources permit.
Pamela Protzel Berman,
Director, Office of Policy, Planning and Partnerships, Agency for Toxic
Substances and Disease Registry.
[FR Doc. 2018-08090 Filed 4-17-18; 8:45 am]
BILLING CODE 4163-70-P
